Autopsy report · NCT01153958
Colposeptine for the Treatment of Bacterial Vaginosis
Cause of deathNo reason given
Life of this trial
- Ran for about 4 months before it stopped.
- 133 participants enrolled.
- Results were posted on the registry 1 year 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Sponsor type
- Industry
- Conditions
- Vaginosis, Bacterial
- Interventions
- Colposeptine; Metronidazole
- Participants
- 133
- Sites
- 5
- Countries
- China
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.